CLYM
Climb Bio Inc
14.10$
-0.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.5% | 89.3% | 85.6% | 99.6% | 99.8% | 71.3% | 63.1% | |
| 99.2% | 83.2% | 27.1% | 32.3% | 84.3% | 40.2% | 21.3% | |
| 99.2% | 83.2% | 78.8% | 91.5% | 96.7% | 69.5% | 60.3% | |
| – | – | 3.8% | 4.8% | 2.2% | 0.5% | – | |
| 3.7% | 12.4% | 3.5% | 4.6% | 2.6% | 2.4% | 4.3% | |
| 3.7% | 12.4% | 3.5% | 4.5% | 2.6% | 2.3% | 4.2% | |
| – | – | – | 0.2% | 0.3% | 0.1% | 0.2% | |
| 3.0% | 4.4% | 0.8% | 0.6% | 0.1% | 0.3% | 1.4% | |
| 96.3% | 87.6% | 96.5% | 95.4% | 97.4% | 97.6% | 95.7% | |
| -34.9% | -114.2% | -43.6% | -89.5% | -141.2% | -105.8% | -172.7% | |
| 54.5% | 47.3% | 7.1% | 19.5% | 24.4% | 22.2% | 40.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.